Key result
Noninvasive multimodality imaging differentiates stable from unstable plaque to guide clinical decision making.
Answers are grounded in this paper and cite their sources.
Cardiovascular disease is one of the leading causes of mortality and morbidity worldwide. Atherosclerosis imaging has traditionally focused on detection of obstructive luminal stenoses or measurements of plaque burden. However, with advances in imaging technology it has now become possible to noninvasively interrogate plaque composition and disease activity, thereby differentiating stable from unstable patterns of disease and potentially improving risk stratification. This manuscript reviews multimodality imaging in this field, focusing on carotid and coronary atherosclerosis and how these novel techniques have the potential to complement current imaging assessments and improve clinical decision making.
No takes yet. Share an insight, caveat, or question.
Daghem et al. (2019) conducted a review in Atherosclerosis. Noninvasive multimodality imaging was evaluated. Noninvasive multimodality imaging can assess atherosclerotic plaque composition and disease activity, helping to differentiate stable from unstable disease and improve clinical decision making.
Synapse has enriched 10 related papers. Consider them for comparative context: